By John Meyer, consultant in financial affairs – Eurasia Business News, February 3, 2025. Article No 1407.
L’Oréal has announced its decision to sell a €3 billion ($3.1 billion) stake in Sanofi back to the French pharmaceutical company. This transaction involves the sale of approximately 29.6 million shares at a price of €101.50 each, reflecting a 2.8% discount from Sanofi’s closing price on January 31, 2025.
Following the completion of this sale and the subsequent cancellation of the repurchased shares, L’Oréal will retain a 7.2% ownership stake in Sanofi’s share capital and hold 13.1% of its voting rights.
L’Oréal’s Chief Financial Officer, Christophe Babule, emphasized the importance of their longstanding relationship with Sanofi, stating that they remain committed to supporting the company’s growth and value creation strategy24.
This move is part of L’Oréal’s strategy to optimize its balance sheet after recent acquisitions and to diversify its financing sources. The company has been active in expanding through significant purchases, including a notable acquisition of the luxury skincare brand Aēsop for $2.6 billion, which has prompted the need for financial adjustments
The transaction is structured as an off-market block trade and is expected to be finalized shortly without any conditions precedent.
Read also : Start investing in Bitcoin using Coinbase
Our community already has nearly 145,000 readers!
Subscribe to our Telegram channel
Follow us on Telegram, Facebook and Twitter
© Copyright 2025 – Eurasia Business News. Article no. 1407.
Eurasia Business News 